These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6209811)
1. [Anti-nucleolar antibodies in patients with connective tissue disease]. Tanaka M Ryumachi; 1984 Jun; 24(3):173-82. PubMed ID: 6209811 [No Abstract] [Full Text] [Related]
2. Studies of antinuclear antibodies in rheumatoid arthritis. Garcia-de la Torre I; Miranda-Mendez L J Rheumatol; 1982; 9(4):603-6. PubMed ID: 6182293 [TBL] [Abstract][Full Text] [Related]
3. Comparison of substrates for the detection of antinuclear antibodies in normals and in patients with connective tissue and other diseases. Lipscomb MF; Cope LD; Stephens GL; Deng JS; Gilliam JN Diagn Immunol; 1984; 2(3):181-7. PubMed ID: 6388982 [TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of antinuclear and anti-native-DNA antibodies in connective tissue diseases]. Guzmán L; González C; Arriagada M; Grisanti M; Meléndez M; Arinoviche R Rev Med Chil; 1982 Jan; 110(1):24-8. PubMed ID: 6760312 [No Abstract] [Full Text] [Related]
6. [Antibodies to soluble nuclear antigens and native DNA in patients with connective tissue diseases with antinuclear antibodies]. Damilano G; Hübscher O; Fernández L; Arana RM Medicina (B Aires); 1983; 43(5):488-94. PubMed ID: 6371438 [No Abstract] [Full Text] [Related]
7. The clinical significance of antinuclear antibodies in connective tissue disease. Pahor A; Krajnc I; Gorenjak M; Holc I Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626 [TBL] [Abstract][Full Text] [Related]
8. Antinuclear antibodies in dermatology. Heffernan MP; Do JH; Mehta J Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133 [TBL] [Abstract][Full Text] [Related]
9. Fatal connective tissue disease with antinuclear antibodies following PUVA therapy. Bruze M; Krook G; Ljunggren B Acta Derm Venereol; 1984; 64(2):157-60. PubMed ID: 6203306 [TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of antibodies against extractible nuclear antigens (ENA) with a view to "mixed connective tissue syndrome" (author's transl)]. Zitnan D; Cebecauer L; Miceková D; Lukác J; Rovenský J; Tauchmannová H Cas Lek Cesk; 1980; 119(8):227-33. PubMed ID: 6966537 [No Abstract] [Full Text] [Related]
14. Clinical characteristics and course in patients with high titer anti-RNP antibodies. Lemmer JP; Curry NH; Mallory JH; Waller MV J Rheumatol; 1982; 9(4):536-42. PubMed ID: 6982334 [TBL] [Abstract][Full Text] [Related]
15. [Positive immunofluorescence reaction in cell nuclei in the undamaged skin of patients with systemic connective tissue diseases]. Plesivcnik M; Vizjak A; Rozman B; Pisek K; Kveder T; Lestan B Reumatizam; 1988; 35(1-6):7-17. PubMed ID: 3077198 [No Abstract] [Full Text] [Related]
16. Finger joint calcinosis followed by osteolysis in a patient with multisystem connective tissue disease and anti-Jo-1 antibody. Cohen MG; Ho KK; Webb J J Rheumatol; 1987 Jun; 14(3):605-8. PubMed ID: 3498039 [TBL] [Abstract][Full Text] [Related]
17. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)]. Benhamou CL; Amor B; Menkes CJ; Delbarre F Ann Med Interne (Paris); 1982; 133(2):72-9. PubMed ID: 6979281 [TBL] [Abstract][Full Text] [Related]
18. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma. Thomas PJ; Kaur JS; Aitcheson CT; Robinson WA; Tan EM Cancer Res; 1983 Mar; 43(3):1372-80. PubMed ID: 6337706 [TBL] [Abstract][Full Text] [Related]